HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Acute therapy of maternal and fetal arrhythmias during pregnancy.

Abstract
Atrial premature beats are frequently diagnosed during pregnancy. Supraventricular tachycardia (atrial tachycardia, atrioventricular nodal reentrant tachycardia, circus movement tachycardia) is diagnosed less frequently. For acute therapy, electrical cardioversion with 50 to 100 J is indicated in all unstable patients. In stable supraventricular tachycardia, the initial therapy includes vagal maneuvers to terminate tachycardias. For short-term management, when vagal maneuvers fail, intravenous adenosine is the first choice drug and may safely terminate the arrhythmia. Ventricular premature beats are also frequently present during pregnancy and are benign in most patients; however, malignant ventricular tachyarrhythmias (sustained ventricular tachycardia, ventricular flutter, or ventricular fibrillation) may occur. Electrical cardioversion is necessary in all patients who are hemodynamically unstable with life-threatening ventricular tachyarrhythmias. In hemodynamically stable patients, initial therapy with ajmaline, procainamide, or lidocaine is indicated. In patients with syncopal ventricular tachycardia, ventricular fibrillation, ventricular flutter, or aborted sudden death, an implantable cardioverter-defibrillator is indicated. In patients with symptomatic bradycardia, a pacemaker can be implanted using echocardiography at any stage of pregnancy. The treatment of the pregnant patient with cardiac arrhythmias requires important modifications of the standard practice of arrhythmia management. The goal of therapy is to protect the patient and fetus through delivery, after which chronic or definitive therapy can be administered.
AuthorsHans-Joachim Trappe
JournalJournal of intensive care medicine (J Intensive Care Med) 2006 Sep-Oct Vol. 21 Issue 5 Pg. 305-15 ISSN: 0885-0666 [Print] United States
PMID16946446 (Publication Type: Journal Article, Review)
Chemical References
  • Anti-Arrhythmia Agents
Topics
  • Anti-Arrhythmia Agents (adverse effects, therapeutic use)
  • Arrhythmias, Cardiac (diagnosis, therapy)
  • Critical Care (methods)
  • Death, Sudden, Cardiac (prevention & control)
  • Electric Countershock
  • Electrocardiography
  • Female
  • Fetal Diseases (diagnosis, therapy)
  • Humans
  • Pregnancy
  • Pregnancy Complications, Cardiovascular (therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: